Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date

Go back to Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
(NASDAQ: ANIX) Delayed: 2.70 -0.07 (2.53%)
Previous Close $2.77    52 Week High
Open $2.82    52 Week Low
Day High $2.82    P/E N/A 
Day Low $2.66    EPS
Volume 476,318